Preventive Kidney Care for Older Adults

Preventive kidney care for older adults addresses the specific risk factors, exposures, and management gaps that most commonly lead to kidney disease onset or progression in adults over 60 — and that, when addressed systematically, can substantially reduce that risk. CKD in older adults is not inevitable. While some age-related kidney function decline is physiological and unavoidable, the progression of CKD to kidney failure is driven by controllable factors: uncontrolled blood pressure, inadequately managed diabetes, nephrotoxic medication exposures, recurrent acute kidney injury events, and the absence of systematic monitoring that would detect early disease before it progresses. This article provides the practical prevention framework for older adults who want to protect their kidney function — covering the highest-yield interventions, the monitoring schedule that detects early disease, and the lifestyle factors that most consistently preserve kidney health across the second half of life. For the companion article covering what changes in kidney biology after 60 and why, see kidney health after age 60. For a complete guide to managing established kidney disease across the lifespan, see the article on living well with kidney disease: a practical roadmap.

Know Your Kidney Health Numbers: What to Monitor and How Often

The most fundamental preventive intervention for older adults is systematic monitoring — because CKD is asymptomatic in its early stages, and the only way to detect it before it causes irreversible damage is through laboratory testing. Older adults who are not monitoring their kidney function regularly are flying blind; any disease that is developing is invisible until it has already caused significant harm. eGFR and creatinine: estimated glomerular filtration rate (eGFR) and serum creatinine should be checked annually in all adults over 60, and every 3–6 months in those with known risk factors (hypertension, diabetes, cardiovascular disease, family history of kidney disease, prior episode of AKI). A single eGFR value below 60, if confirmed on a repeat test at least three months later, meets the diagnostic criteria for CKD and should prompt nephrology referral or at minimum a focused evaluation of the cause. Urine albumin-to-creatinine ratio (ACR): proteinuria — protein leaking into the urine — is the most sensitive early marker of glomerular damage from hypertension and diabetes, detectable years before eGFR begins to decline. Annual ACR testing in all adults over 60 with hypertension or diabetes, and every 3–6 months in those with known CKD or ACR above 30 mg/g, allows detection of early glomerular damage at a stage when management can meaningfully slow or halt progression. For a detailed explanation of what ACR measures and how to interpret the results, the article on albumin-to-creatinine ratio: what adults should know covers the clinical significance. Blood pressure: home blood pressure monitoring — not relying solely on office readings — is particularly important for older adults, whose office readings are more frequently elevated by white-coat hypertension and who often have orthostatic hypotension that is missed by seated office measurements. A home blood pressure log covering at least two weeks before each appointment provides the data needed to evaluate whether blood pressure control is adequate in real-world conditions. The complete framework for blood pressure monitoring in kidney health is covered in the blood pressure log for kidney health. Blood glucose (HbA1c): for older adults with diabetes, HbA1c should be monitored every 3–6 months when management is being adjusted and every 6 months when stable. Poorly controlled blood glucose is one of the two most important modifiable causes of CKD in older adults; regular monitoring is the mechanism through which management targets are evaluated. Medication review: the complete medication list — prescription, OTC, and supplements — should be reviewed against the current kidney function at every appointment, not just the annual physical. Renally-cleared medications that are safe at normal GFR may accumulate to toxic levels as GFR declines; medications that were safe at eGFR 65 may require dose adjustment at eGFR 45. The NIDDK guidance on CKD prevention and monitoring, at the NIDDK CKD management page, provides the clinical context for understanding the monitoring schedule and what each result means.

Blood Pressure Management: The Highest-Yield Prevention Intervention

Hypertension is both the most common modifiable risk factor for CKD in older adults and the most damaging ongoing exposure once CKD is established. Blood pressure control is not just a preventive measure — it is simultaneously preventive for those without CKD, and the most effective intervention for slowing progression in those who have it. Why blood pressure damages kidneys: persistently elevated blood pressure causes intraglomerular hypertension (elevated pressure within the kidney’s filtering units), which damages the glomerular capillaries over time, triggers proteinuria, and accelerates nephron loss. This damage accumulates over years and is largely irreversible; preventing it requires consistent blood pressure control over the same time frame. Target blood pressure in older adults: the evidence-based target for adults with hypertension and kidney disease is below 130/80 mmHg. In frail older adults with significant fall risk, orthostatic hypotension, or multiple comorbidities, the benefit-risk calculus may support a slightly higher target — but this should be explicitly evaluated with the care team, not assumed. A blood pressure of 150/90 in an older adult does not represent “good enough” control just because it is less extreme than 180/110; the kidney damage accumulates at 150/90 as well, just more slowly. Home blood pressure monitoring in older adults: white-coat hypertension — elevated blood pressure in the clinical setting driven by anxiety — is more prevalent in older adults and leads to overtreatment. Masked hypertension — normal blood pressure in the office but elevated at home — is also more prevalent in older adults and leads to undertreatment. Home blood pressure monitoring resolves both of these problems by providing the real-world distribution of blood pressure that determines actual cardiovascular and kidney risk. Medication adherence: antihypertensive medication adherence is lower in older adults due to pill burden, side effects, cognitive issues affecting medication management, and financial constraints. Addressing adherence barriers specifically — pill organizers, automatic refill, financial assistance programs, simplification of the regimen where possible — is as important as medication selection. Uncontrolled blood pressure from non-adherence causes the same kidney damage as uncontrolled blood pressure from inadequate treatment. The KDIGO guidelines on blood pressure management in CKD, at the KDIGO CKD guidelines page, provide the evidence base for blood pressure targets and treatment selection in CKD patients.

Diabetes Management and SGLT2 Inhibitors: Protecting Kidneys in Older Adults With Diabetes

Diabetes is the leading cause of CKD in adults worldwide and the leading cause of kidney failure requiring dialysis. For older adults with diabetes and CKD, diabetes management is not just metabolic — it is directly kidney-protective when done well, and directly kidney-damaging when done poorly. Glycemic control targets in older adults with CKD: the HbA1c target for older adults with diabetes and CKD is individualized — generally 7.0–7.5% for healthy older adults, 7.5–8.0% for those with comorbidities and limited life expectancy, and 8.0–8.5% for frail older adults or those with cognitive impairment and hypoglycemia unawareness. The rationale for less aggressive targets in some older adults is the risk of hypoglycemia — which is more dangerous in older adults due to falls, cardiac arrhythmias, and the impaired recovery response that accompanies reduced kidney function. SGLT2 inhibitors (canagliflozin, dapagliflozin, empagliflozin): this class of diabetes medications has demonstrated kidney-protective effects that are partially independent of their glucose-lowering effect, including reduction in proteinuria, reduction in intraglomerular hypertension, and slowing of eGFR decline. In clinical trials (CREDENCE, DAPA-CKD, EMPA-KIDNEY), SGLT2 inhibitors reduced the risk of kidney failure by 30–40% in patients with diabetic nephropathy and significant proteinuria. They are now guideline-recommended for most patients with type 2 diabetes and CKD who meet the eGFR criteria (generally eGFR ≥20–25). Older adults with type 2 diabetes and CKD who are not on an SGLT2 inhibitor should specifically ask their care team whether one is appropriate for their situation. Avoiding hypoglycemia: hypoglycemia in an older adult with CKD is doubly dangerous — the kidneys’ impaired ability to participate in gluconeogenesis (producing glucose from non-carbohydrate sources) means that recovery from hypoglycemia is slower, and the cardiovascular consequences of hypoglycemia (arrhythmias, falls, cardiac ischemia) are more severe in an older adult. Medications with significant hypoglycemia risk (sulfonylureas, insulin) require careful titration and monitoring in older adults with CKD. The NKF guidance on diabetes and kidney health, at the NKF CKD resource page, provides accessible context for understanding the kidney-diabetes interaction. For a comprehensive treatment of protecting kidney health in adults with diabetes, the article on how to protect your kidneys with diabetes covers the full management framework.

Lifestyle Interventions With the Strongest Evidence in Older Adults

Several lifestyle interventions have documented kidney-protective effects in older adults and are worth prioritizing in a preventive kidney care framework specifically because they address mechanisms that are particularly active in this age group. Smoking cessation: smoking accelerates CKD progression through endothelial damage, renal vasoconstriction, and increased cardiovascular risk. The kidney-protective benefit of smoking cessation is present at any age — older adults who quit smoking, even after decades of smoking, reduce their CKD progression rate. Smoking cessation counseling and pharmacotherapy (varenicline, nicotine replacement, bupropion) are appropriate and effective in older adults. Physical activity: regular physical activity reduces blood pressure, improves insulin sensitivity, reduces inflammation, and improves cardiovascular outcomes — all of which are relevant to kidney health. Walking 30 minutes five days per week is the most consistently beneficial exercise regimen in older adults with CKD, achievable without special equipment and with a low injury risk. Older adults with specific limitations (severe arthritis, heart failure, severe anemia) should discuss appropriate exercise modification with their care team, but physical inactivity should not be the default. Dietary sodium reduction: high dietary sodium intake raises blood pressure, increases proteinuria, and reduces the effectiveness of ACE inhibitors and ARBs — all of which accelerate CKD progression. A target sodium intake of ≤2,000–2,300 mg per day (roughly 5–6 grams of salt) represents a meaningful reduction from the average adult intake of 3,400 mg/day and is achievable through reducing processed food, restaurant food, and added salt at the table without severe dietary restriction. Maintaining a healthy weight: obesity is an independent risk factor for CKD progression through multiple mechanisms including intraglomerular hypertension, insulin resistance, and chronic low-grade inflammation. In older adults, who are at high risk of sarcopenic obesity (excess body fat with low muscle mass), weight management that preserves muscle while reducing fat — through physical activity and adequate protein intake — is more appropriate than caloric restriction alone. Adequate hydration: chronic mild dehydration — common in older adults due to reduced thirst sensation — causes chronic renal hypoperfusion that contributes to kidney function decline over time. Maintaining a consistent daily fluid intake (approximately 1.5–2.5 liters, depending on climate, activity, and medical conditions) supports kidney perfusion and urine concentration. For adults with heart failure or advanced CKD who have fluid restrictions, the appropriate intake should be discussed with the care team. The StatPearls clinical reference on CKD prevention and management, at the StatPearls CKD reference, provides the evidence context for these interventions. The complete monitoring and management framework for older adults with established or at-risk kidney function is covered across the Horizon Health Guide kidney health series, beginning with home kidney health monitoring: what to track.

Sources: NIDDK CKD Management · KDIGO CKD Guidelines · National Kidney Foundation · StatPearls: CKD Management

Avoiding the Most Common Preventable Causes of Kidney Damage in Older Adults

While blood pressure control and diabetes management are the most important long-term prevention interventions, several discrete, avoidable exposures cause acute kidney damage in older adults that, if repeated, accelerates the underlying chronic decline. Understanding and actively avoiding these exposures is a concrete and immediately actionable preventive strategy. NSAID avoidance: non-steroidal anti-inflammatory drugs — ibuprofen, naproxen, aspirin at analgesic doses, and many prescription NSAIDs — are among the most commonly used medications in older adults and among the most nephrotoxic. NSAIDs inhibit prostaglandins that maintain glomerular perfusion under conditions of reduced cardiac output or blood volume; in an older adult with reduced renal reserve, normal blood pressure, or mild dehydration, NSAID use can precipitate acute kidney injury that may or may not be fully reversible. Older adults with eGFR below 60 should discuss with their care team what to use instead of NSAIDs for pain management — acetaminophen (within the safe dose range), topical NSAID preparations (which have lower systemic absorption), physical therapy, and in some cases short courses of low-dose oral NSAIDs with close monitoring may be appropriate alternatives. The key principle is that NSAIDs should not be taken for granted as safe OTC pain management by older adults with reduced kidney function. Contrast agent caution: iodinated contrast used in CT scans can cause contrast-induced acute kidney injury, particularly in older adults with eGFR below 45 who are dehydrated at the time of the study. Before any contrast-enhanced CT, the ordering provider should be informed of the current creatinine and eGFR; for patients at significant risk, pre-hydration protocols and consideration of alternative imaging (non-contrast CT, ultrasound, MRI with non-nephrotoxic gadolinium where appropriate) should be discussed. Patients should not assume that contrast safety has been evaluated unless they have specifically confirmed it with the ordering provider. Herbal and traditional medicine products: several herbal products are directly nephrotoxic, including traditional Chinese herbal medicines containing aristolochic acid (associated with rapidly progressive kidney fibrosis, aristolochic acid nephropathy), certain Ayurvedic preparations containing heavy metals, star fruit (carambola) in patients with CKD (which can cause acute oxalate nephropathy and neurotoxicity), and high-dose chromium, germanium, and other trace minerals sometimes marketed as health supplements. Older adults who use any traditional or herbal medicine products should discuss these specifically with their nephrologist rather than assuming that “natural” means safe. For a comprehensive evaluation framework for supplement safety in CKD, the article on supplement safety for people with kidney disease covers the risks and the evaluation approach. Infection management: infections — particularly urinary tract infections, pneumonia, and sepsis — are major causes of acute kidney injury in older adults. Prompt recognition and treatment of infections before they progress to systemic illness is a kidney-protective strategy. Signs of UTI in older adults can be atypical — confusion, agitation, loss of appetite, or falls rather than classic dysuria and frequency — and may be missed or attributed to other causes. Any unexplained acute change in mental status or behavior in an older adult should prompt evaluation that includes urinalysis. Dehydration prevention during illness: acute illness with vomiting, diarrhea, fever, or reduced oral intake causes dehydration that can rapidly precipitate AKI in older adults with reduced kidney reserve. Having a specific plan for managing hydration during illness — oral rehydration solutions, when to seek medical evaluation, whether to hold certain medications during acute illness — prevents the situation where a recoverable AKI becomes irreversible because the evaluation and treatment were delayed. This plan should be discussed with the care team in advance rather than improvised during an acute illness episode.

Building a Preventive Kidney Care Routine: Annual Checklist for Older Adults

Translating the preventive kidney care framework into a practical annual routine ensures that the monitoring and management activities happen consistently rather than sporadically. The following checklist describes the annual preventive kidney care activities most relevant to older adults at risk for or with early CKD. Annual lab panel (at minimum): serum creatinine and eGFR, urine albumin-to-creatinine ratio (random or first-morning urine sample), HbA1c if diabetic, fasting glucose if non-diabetic but with other risk factors, complete metabolic panel including electrolytes, and blood pressure at the time of the lab draw. Adults with known CKD stages 2–3a should have labs every 6 months; stage 3b and beyond should follow the monitoring schedule set by their nephrologist. Annual medication review: compare the current medication list against the current eGFR. For renally-adjusted medications, confirm that the current dose is appropriate for the current kidney function — not the function at the time the medication was prescribed. Include OTC medications, supplements, and herbal products in this review. Annual blood pressure target review: confirm with the care team that the current blood pressure target is still appropriate given the current clinical status, and review whether the home blood pressure log average over the past 3–6 months is meeting that target. If not, identify and address the gap — whether medication, adherence, sodium intake, or another factor. Annual specialist referral assessment: for older adults with eGFR declining toward 45 or below, or with significant proteinuria, discuss with the primary care provider whether nephrology referral is appropriate. CKD stages 3b and beyond, or any CKD with ACR above 300 mg/g, generally warrants nephrology co-management. Annual nutritional and dietary assessment: for older adults with CKD stage 3 or beyond, annual nutritional assessment by a renal dietitian provides individualized guidance that accounts for the evolving dietary targets as kidney function changes. Malnutrition is a significant risk in older adults with CKD; an annual dietitian assessment identifies this risk before it becomes severe. Annual medication toxicity screen: ask the care team explicitly whether any current medication’s dose needs adjustment based on the current kidney function — not as a general question but as a specific request to review the medication list against the most recent eGFR. The StatPearls reference on CKD prevention, available at the StatPearls CKD reference, covers the clinical monitoring standards for CKD prevention and early management. For adults who are building the home monitoring component of their preventive kidney care routine, the article on home kidney health monitoring: what to track provides the complete framework for daily and weekly monitoring that supports the annual clinical assessments.

Preventive kidney care for older adults is most effective when it is integrated into the existing routine of managing other chronic conditions rather than treated as a separate, additional task. Blood pressure monitoring that is already happening for hypertension management serves the kidney health goal simultaneously. HbA1c monitoring that is already happening for diabetes management generates the data that evaluates kidney protection from glycemic control. The annual lab panel that includes creatinine and eGFR can be added to existing bloodwork draws without additional visits. The medication review that should happen at every care visit can include a systematic kidney-function-adjusted dose check. The structures are already in place for most older adults managing chronic conditions — adding the kidney-specific lens to existing monitoring and management practices is the most efficient and sustainable path to effective preventive kidney care. For a complete guide to the practical daily and annual management of kidney health that integrates all of these elements, the article on long-term kidney care plan provides the organizing framework that connects monitoring, medication management, appointment preparation, and progression planning into a coherent patient-managed system.